Device Promotional Activities Monitored By Competitors, May Hike Costs
This article was originally published in The Gray Sheet
Executive Summary
FDA's slowed pace in dealing with advertising and promotion violations may lead to added costs for manufacturers opting to tap their own funds to take action against perceived violations by competitors
You may also be interested in...
CDRH Promotion/Advertising Merging With OC Under Reorganization Plan
FDA's Center for Devices & Radiological Health plans to fold the Promotion & Advertising Policy Staff into the Office of Compliance
CDRH Promotion/Advertising Merging With OC Under Reorganization Plan
FDA's Center for Devices & Radiological Health plans to fold the Promotion & Advertising Policy Staff into the Office of Compliance
Smith & Nephew Supartz Promotional Claims Draw Scrutiny From FDA, NAD
Smith & Nephew should take steps to ensure that device promotional brochures with claims not intended for U.S. markets are not circulated domestically, according to the National Advertising Division of the Council of Better Business Bureaus